1125832

Elizabeth L. Hohmann, M.D. — FEI 3005482318

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 17, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Clinical Investigator (CI)